Stanford Health Care (SHC) is world-renowned for advanced patient care, particularly for the treatment of cancer. SHC is recognized by U.S. News & World Report as one of "America's Best Hospitals," currently ranked #13 in the U.S on the Best Hospital Honor Roll. SHC is a National Cancer Institute (NCI) Designated Cancer Center.
The Hematology/Oncology Residency at SHC is a 12-month PGY-2 specialty training program that offers extensive hematology and oncology experiences at Stanford Comprehensive Cancer Center. Two applicants are accepted per year.
The program is designed to transition PGY-1 residency graduates from general practice to specialized practice focused on the care of patients with oncologic and/or hematologic disorders. Residency graduates will be equipped to participate as integral members of interdisciplinary teams, assuming responsibility for pharmaceutical care.
Throughout the program, the resident will gain practical experience in the management in neoplastic diseases as well as cancer-related and cancer treatment-related disorders. Due to the prominent use of investigational drugs in the treatment of cancer, the resident will also gain the knowledge and skills necessary to practice effectively in clinical research environments. The resident will be able to manage the preparation, distribution, and disposal of hazardous medications in both inpatient and ambulatory settings. Experiences will also include leadership in formulary decision-making for cancer-related medications.
Groomed for practice leadership, the PGY-2 Hematology/Oncology residents will be able to successfully serve health care organizations with the clinical and practice skills necessary for effective decision-making in the treatment of oncologic and hematologic disorders.
RESIDENCY CONTACT INFORMATION
Residency Program Director: Eun Jeong Kim, Pharm.D., MS, BCOP
Stanford Health Care Department of Pharmacy 300 Pasteur Drive, Room H0301 Stanford, CA 94305-5616
The goal of the PGY-2 Hematology/Oncology Residency Program is to provide a broad experience-based foundation in hematology/oncology, to develop his/her clinical skills, and to prepare for a comprehensive clinical practice in hematology/oncology. Upon completion of the residency program, the resident will:
Provide optimal clinical care to patients with oncologic and/or hematologic disorders
Function as an effective member of the health care team
Educate health care professionals, students, patients, and the community about effective and safe medication use
Develop excellent written and verbal communication skills
Demonstrate time management and problem-solving skills
Become a leader within the pharmacy profession
The Hematology/Oncology Specialty Residency is accredited by the American Society of Health System Pharmacists (ASHP). The program follows the ASHP Residency Learning System (RLS) and its goals and learning objectives are consistent with standards developed by ASHP.
Orientation/Training (1-2 weeks)
Inpatient Oncology (4-6 weeks)
Inpatient Hematology (4-6 weeks)
Inpatient Chemotherapy Admission (4 weeks)
Inpatient Blood and Marrow Transplantation (BMT) (4-5 weeks)
* A maximum of one off-site rotation will be permitted.
Outpatient Hematology/Oncology/BMT Clinics
Completion of a research project presented at the Western States Conference and/or HOPA (Hematology/Oncology Pharmacy Association) annual meeting.
Chemotherapy Preparation and Dispensing
Active participation in interdisciplinary patient care rounds
Participate in educating pharmacy, medical, and nursing staff as well as PGY-1 pharmacy residents and students
Teaching certificate program (optional)
Prepare and present a hematology/oncology related drug monograph for the Pharmacy & Therapeutics Committee
Attend hematology/oncology related committee meetings and teaching sessions
Staff 16 hours every 3 weeks in the hematology/oncology pharmacy satellite
Compensation and Benefits
PGY-2 residents receive a competitive annual stipend of approximately $81,000 with full benefits, including an excellent health care benefits package and 10 days paid time off (PTO). In addition, the PGY-2 resident will enjoy educational leave and a stipend to attend and participate at various pharmacy conferences throughout the year.
Completion of Doctor of Pharmacy degree from an ACPE-accredited school or college of pharmacy
Completion of an ASHP-accredited PGY-1 residency program
Participate in an on-site interview at Stanford Health Care
Obtain licensure to practice pharmacy in the state of California before October 1